Hims & Hers vs NiceRx
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
People who want a familiar consumer-brand app experience and don't need tirzepatide.
- semaglutide
- $199/mo
- tirzepatide
- Not confirmed for Hims & Hers.
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
Before enrolling
Tirzepatide pricing inconsistently disclosed
Desk Score
Patients seeking batch-tested compounded GLP-1 with transparent entity disclosure.
- semaglutide
- $199/mo
- tirzepatide
- $299/mo
Before enrolling
New York was dropped from the service area since our last read, with no notice anywhere on the site; also unavailable in Alaska, Mississippi, New Jersey and Kansas
Our review of Hims & Hers gives it 79/100 (C+), while our review of NiceRx gives it 78/100 (C+). The score breakdown shows where each provider does better.
Desk Score, dimension by dimension
Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.
79/100
C+
78/100
C+
The spec sheet
Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.
| Field | Hims & Hers | NiceRx |
|---|---|---|
| Semaglutide | $199/moFull plan terms$199/mo | $199/moFull plan terms$199/mo month-to-month (compounded); $99 for the first month |
| Tirzepatide | Not confirmed for Hims & Hers. | $299/moFull plan terms$299/mo month-to-month (compounded); $199 for the first month |
| Coverage | All 50 states | 45 states |
| Brand-name | Not confirmed here | Not confirmed here |
| Oral option | Not confirmed here | Not confirmed here |
| Best for | People who want a familiar consumer-brand app experience and don't need tirzepatide. | Patients seeking batch-tested compounded GLP-1 with transparent entity disclosure. |
| Desk Score | 79/100C+ | 78/100C+ |
The verdict
Desk pick — Hims & HersHims & Hers has the higher Desk Score, but NiceRx may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.
People who want a familiar consumer-brand app experience and don't need tirzepatide.
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
Patients seeking batch-tested compounded GLP-1 with transparent entity disclosure.
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.
More head-to-heads
- CoreAge Rx vs Hims & Hers
- CoreAge Rx vs NiceRx
- Hims & Hers vs Ondra Health
- HealthRX vs NiceRx
- Hims & Hers vs Vaylen
- NiceRx vs RestorLife Med
Or see the full comparison hub and the complete ranking.